Maintenance of personal and environmental hygiene
Use of harmful irritants in the workplace should be regulated
Efforts to raise knowledge of potential allergies and irritants through education
promoting safe working conditions and practices
health screenings before and after employment and on a regular basis Topical antibiotics should not be used to prevent infection in wounds after surgery. When they are used, it is inappropriate, and the person recovering from surgery is at significantly increased risk of developing contact dermatitis. Treatment
Self-care
If blistering develops, cold moist compresses applied for 30 minutes, 3 times a day can offer relief. Calamine lotion may relieve itching. Oral antihistamines such as diphenhydramine (Benadryl, Ben-Allergin) can relieve itching. Avoid scratching. Immediately after exposure to a known allergen or irritant, wash with soap and cool water to remove or inactivate most of the offending substance. For mild cases that cover a relatively small area, hydrocortisone cream in nonprescription strength may be sufficient. Weak acid solutions (lemon juice, vinegar) can be used to counteract the effects of dermatitis contracted by exposure to basic irritants. A barrier cream, such as those containing zinc oxide (e.g., Desitin, etc. ), may help protect the skin and retain moisture. Medical care
If the rash does not improve or continues to spread after 2–3 of days of self-care, or if the itching and/or pain is severe, the patient should contact a dermatologist or other physician. Medical treatment usually consists of lotions, creams, or oral medications. Corticosteroids. A corticosteroid medication like hydrocortisone may be prescribed to combat inflammation in a localized area.
All children, according to the U.S. vaccination schedule, should receive four doses, at two months, four months, six months, and again between one year and fifteen months of age.The CDC updated the pneumococcal vaccine guidelines for adults 65 years of age or older in 2019.In October 2021, the CDC recommended that adults 65 years of age or older who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown should receive a pneumococcal conjugate vaccine (either PCV20 or PCV15). If PCV15 is used, this should be followed by a dose of PPSV23. The CDC recommended that adults aged 19 to 64 years with certain underlying medical conditions or other risk factors who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown should receive a pneumococcal conjugate vaccine (either PCV20 or PCV15). If PCV15 is used, this should be followed by a dose of PPSV23. Efficacy
Prevnar-7 is designed to stop seven of about ninety pneumococcal serotypes which have the potential to cause invasive pneumococcal disease (IPD). In 2010, a 13-valent vaccine was introduced. Each year, IPD kills approximately one million children worldwide. Since approval, Prevnars efficacy in preventing IPD has been documented by a number of epidemiologic studies. There is evidence that other people in the same household as a vaccinee also become relatively protected.